EphA3 Maintains Tumorigenicity and Is a Therapeutic Target in Glioblastoma Multiforme Bryan W. Day, Brett W. Stringer, Fares Al-Ejeh, Michael J. Ting, John Wilson, Kathleen S. Ensbey, Paul R. Jamieson, Zara C. Bruce, Yi Chieh Lim, Carolin Offenhäuser, Sara Charmsaz, Leanne T. Cooper, Jennifer K. Ellacott, Angus Harding, Lucie Leveque, Po Inglis, Suzanne Allan, David G. Walker, Martin Lackmann, Geoffrey Osborne, Kum Kum Khanna, Brent A. Reynolds, Jason D. Lickliter, Andrew W. Boyd Cancer Cell Volume 23, Issue 2, Pages (February 2013) DOI: /j.ccr Copyright © 2013 Elsevier Inc. Terms and Conditions Terms and Conditions
Figure 1 Cancer Cell , DOI: ( /j.ccr ) Copyright © 2013 Elsevier Inc. Terms and Conditions Terms and Conditions
Figure 2 Cancer Cell , DOI: ( /j.ccr ) Copyright © 2013 Elsevier Inc. Terms and Conditions Terms and Conditions
Figure 3 Cancer Cell , DOI: ( /j.ccr ) Copyright © 2013 Elsevier Inc. Terms and Conditions Terms and Conditions
Figure 4 Cancer Cell , DOI: ( /j.ccr ) Copyright © 2013 Elsevier Inc. Terms and Conditions Terms and Conditions
Figure 5 Cancer Cell , DOI: ( /j.ccr ) Copyright © 2013 Elsevier Inc. Terms and Conditions Terms and Conditions
Figure 6 Cancer Cell , DOI: ( /j.ccr ) Copyright © 2013 Elsevier Inc. Terms and Conditions Terms and Conditions